MM-141

Pancreatic cancer study failure cripples a Merrimack drug, forcing a coup de grâce and pipeline retreat
Endpoints
Mon, 06/25/18 - 09:24 am
pancreatic cancer
MM-141
Merrimack Pharmaceuticals
Preclinical Study Results of Merrimack's MM-141 Published in Molecular Cancer Therapeutics
Yahoo/Benzinga
Tue, 02/18/14 - 08:58 am
Merrimack Pharmaceuticals
MM-141